I can tell you Dave my patience are wearing very thin for

New Post Public Reply Private Reply Replies (5) Message Board
Anaconda83 Daveludlow #16955
I can tell you Dave my patience are wearing very thin for Gerald and not the company itself. The fact of the matter is for me is that my cost basis is hovering around this area. I wasn't one of the people who bought in at .02, .03, .04, etc. It is always around the corner with this guy. Each passing week we are still range bound, I am getting more and more irritated. The rocket ship mania has taken hold of everyone, myself included. Everyone (once again, myself included) is waiting for the day where the PR that creates the massive pop happens.

Gerald gave everyone this impression. But also, no one has any idea what the heck is going on with this company. He gets his hooks into people by throwing out many possible scenarios to try to create the perception that massive short term share appreciation is coming. For example, how many different ways has he stated he is going to handle the diagnostics division? Everyone then theorycrafts and tries to value each possible way he can handle it with the result being each one seems better than the last. Then he hides behind his veil of secrecy using a "strategic code of silence" to justify it. It is so infuriating. I very well understand that for strategy and leverage sake, you cannot show your hand. But he is not doing that. He is playing four hands and telling shareholders what cards he is holding, but then will not further elaborate due to "secrecy". The "secrecy" is also responsible for creating this mania.

The man is infuriating. Maybe he feels like he has to do this to prevent Amarantus from becoming irrelevant? Maybe he is trying to stave off a mass exodus? If you had a Biotech almanac from Back to the Future and you knew definitively that this company was going to continue spinning it's tires in the mud until say, arbitrarily, September, no one in their right mind would hold this company. They would sell, make money somewhere else, and buy back in August. But that is impossible. He has his hooks in everyone, and everyone is petrified to miss the big move which is always next week. As time goes on, the paranoia of missing the big move grows even more. The longer we are holding it, the worse it becomes. I can't sell it because I have dealt with this long enough that I don't want to miss "next week." He is definitely playing shareholders emotions.

He is always constantly evaluating his options. To be honest, I think the people in this forum are evaluating his options more often than he is. I really believe he already knows how he wants to handle it, he is just trying to figure out a way to squeeze the most value out of the play. (Which is fine.) Just don't get everyone salivating with all sorts of possible scenarios and then clam up, when in fact, he is probably just trying to exploit one opportunity to the fullest (one again, which is fine.) Best way to handle it is to tell shareholders, "We are currently evaluating our options with Dx for greatest value." Instead, he dances around and now everyone is worried about an IPO, spinoff, sale, partnership, etc, etc. Uncertainty is so dog gone hard to place a valuation on.

Amarantus Bioscience Holdings (AMBS) Stock Research Links

AMBS Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Japan's RWE Market Transformation: TXP's Insightful Whitepaper

Updated Category News Views 25

Unraveling the Real-World Evidence Landscape in Japan The folks at TXP Medical just dropped a bombshell of a whitepaper that'll have Medical Affairs departments buzzing. Imagine waking up to a market that's exploding by over 500% in just a decade—yeah, I'm talking about the EMR-derived data market in Japan. These guys are saying it's gonna shoot from ¥3.9 billion in...

Continue Reading
Xi Jinping's Vision for China's Financial Evolution

Updated Category News Views 174

Xi's Blueprint for Financial Strength Xi Jinping isn't just whistling Dixie when it comes to reshaping China's financial landscape. His vision is about more than pushing paper; it's about embedding honesty, prudence, and traditional values into the very DNA of China's financial sector. When he talks about enhancing both hard and soft power, he’s thinking wider than...

Continue Reading
Curaleaf Eyes Aurora Amid Alternative from Organigram

Updated Category News Views 65

Curaleaf's Determined Pursuit of Aurora Another day, another chess move in the cannabis world. Curaleaf is standing tall amid talk of a buyout, putting a foot forward to highlight its determination in the battle for Aurora. They've put forth an alternative to the proposal poised by Organigram, raising stakes and eyebrows alike. Aurora Cannabis is in the middle of a dance...

Continue Reading
PRIMA Invests £10M to Propel CC Forum's Global Reach

Updated Category News Views 123

Strategic Commitment for Global Impact You've got to hand it to these folks—they're on a mission to roll up their sleeves and tackle climate change head-on. Max Studennikoff, the brains behind CC Forum, just inked a Letter of Intent with Alexander Zhardanovsky, founder of PRIMA, punctuated by an eye-popping £10 million pledge. It's all about boosting the Forum’s...

Continue Reading
Pyramid Pharma Takes On 13th Blood Cancer Therapy Product

Updated Category News Views 64

Pyramid Pharma: Breaking New Ground in Blood Cancer Treatments There's a new player making waves in the battle against rare blood cancers: Pyramid Pharma Services. This U.S.-based contract development and manufacturing organization is stepping up its game by finessing a cartridge-based product designed to treat those rare and tricky blood maladies. The canvas? A...

Continue Reading
Class Action Targets Coastal Financial Over Missteps

Updated Category News Views 32

New Crosshairs on Coastal Financial Corporation Man, it's another day and yet another fiasco in the corporate world. Late-breaking news from the trenches alerts us that Coastal Financial Corporation is in the legal spotlight. Yeah, you heard me right. We're talking about NASDAQ:CCB, the darlings turned defendants courtesy of recent allegations that could rock their stock....

Continue Reading
Atlas-SSI Expands Grip in Water Control Space

Updated Category News Views 86

Atlas-SSI Makes Waves with Linita Acquisition Here's the kind of news that makes an old market hound sit up and take notice. Atlas-SSI, the big cheese in North America for water management solutions, has gone and snagged Linita Design & Manufacturing. Why's this worth talking about? Linita isn't just any player—they've been crafting custom-engineered hydro-mechanical...

Continue Reading
Cloud Software Group Amends $2B Cash Tender Offer

Updated Category News Views 22

Cloud Software Group is stirring the pot with an amendment that'll have bondholders looking twice at their portfolios. On November 3, 2026, the company announced a tweak to its cash tender offer, bumping up the payment for its 9.00% Senior Secured Second Lien Notes due 2029. The payout now jumps from $1,017.50 to $1,022.50 for each $1,000 of principal. If you're holding...

Continue Reading
Differentia Bio's AI: Transforming Drug Development Dynamics

Updated Category News Views 51

The Future of Drug Development: AI's New Role When it comes to pharmaceutical R&D, Some outfits are playing pin the tail on the donkey, but Differentia Bio over here is sharpening the pin with some futuristic gadgetry. Yep, they're jazzing up the game with AI-powered digital twins, building lifelike disease environments that predict therapeutic outcomes with precision...

Continue Reading
Multiconsult's Q3 2026 Results: A Gradual Rebound

Updated Category News Views 30

Peering into the Q3 Crystal Ball When a company drops its quarterly results, it's like unveiling a new episode in an ongoing drama, and the Multiconsult ASA (Oslo: MULTI) saga is no exception. In their third quarter of 2026, the performance started to show signs of life following a somewhat sluggish run. While the numbers aren't sky-high, they're a solid indication that...

Continue Reading

Top 5 Most Recently Viewed Articles

Mobilizing for Equality: Texas AAPI Community Stands United

Updated Category News Views 275

Mobilizing for Equality: Texas AAPI Community Stands United Communities across Texas are coming together in a powerful display of solidarity against discriminatory Senate Bill 17 (SB 17) and House Bill 17 (HB 17). Both pieces of legislation propose to ban or severely restrict real estate ownership for certain foreign nationals, all while cloaked in the guise of protecting...

Continue Reading
Duke Energy Foundation's Commitment to Community Resilience Grows

Updated Category News Views 252

Duke Energy Foundation's Commitment to Community Resilience Duke Energy Foundation, along with Duke Energy, has made a significant impact by investing over $33 million in nonprofit organizations. This funding supports efforts aimed at enhancing community resilience, emergency preparedness, and disaster relief activities. The partnership extends across multiple states,...

Continue Reading
eCential Robotics Announces New Leaders to Boost Growth in US

Updated Category News Views 111

eCential Robotics Welcomes New Leadership to Accelerate Growth in the U.S. eCential Robotics, an innovator in surgical robotics, is thrilled to announce the recent appointments of Lisa Jacobs as President for North America and Matthieu Ville as Vice President of Marketing. These strategic hires are designed to bolster the company's growth and innovation efforts in the...

Continue Reading
Michelin's Latest Share Buyback Update Everyone Should Know

Updated Category News Views 220

Understanding Michelin's Share Buyback Program Michelin, a leader in tire manufacturing and innovation, is continuously taking steps to enhance its shareholder value. Investors often look for tangible actions reflecting a company's commitment to their financial growth. One of the most significant methods companies utilize to support their stock price and return capital to...

Continue Reading
InterDigital Boosts Third Quarter Forecast Following License Deal

Updated Category News Views 198

InterDigital's Promising New License Agreement and Q3 Outlook Smartphone Licensing Agreement Enhances Revenue Predictions Recently, InterDigital, Inc. (Nasdaq: IDCC), a prominent player in the mobile technology field, announced an exciting update that significantly alters its revenue expectations for the third quarter. The company has secured a major licensing agreement...

Continue Reading